期刊
BIOCONJUGATE CHEMISTRY
卷 25, 期 2, 页码 406-413出版社
AMER CHEMICAL SOC
DOI: 10.1021/bc4005427
关键词
-
类别
资金
- Comprehensive Cancer Center of Wake Forest University
- Department of Defense Prostate Cancer Research Program [093606]
- Comprehensive Cancer Center of Wake Forest University [P30 CA012197]
- NIH [1S10RR17846]
- NCI [5P30CA12197]
Doxorubicin (Dox) is widely used for breast cancer treatment but causes serious side effects including cardiotoxicity that may adversely impact patient lifespan even if treatment is successful. Herein, we describe selective conjugation of Dox to a single site in a DNA hairpin resulting in a highly stable complex that enables Dox to be used more effectively. Selective conjugation of Dox to G15 in the hairpin loop was verified using site-specific labeling with [2-N-15]-2'-deoxyguanosine in conjunction with [H-1-N-15] 2D NMR, while 1:1 stoichiometry for the conjugate was validated by ESI-QTOF mass spectrometry and UV spectroscopy. Molecular modeling indicated covalently bound Dox also intercalated into the stem of the hairpin and stability studies demonstrated the resulting Dox-conjugated hairpin (DCH) complex had a half-life >30 h, considerably longer than alternative covalent and noncovalent complexes. Secondary conjugation of DCH with folic acid (FA) resulted in increased internalization into breast cancer cells. The dual conjugate, DCH-FA, can be used for safer and more effective chemotherapy with Dox and this conjugation strategy can be expanded to include additional anticancer drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据